Key result
Hematopoietic CCL3 deficiency cuts male adipose tissue mass ~50% and reduces atherosclerosis in mice.
Answers are grounded in this paper and cite their sources.
Reveals that hematopoietic CCL3 deficiency reduces atherosclerosis, plasma lipids, and adiposity in hyperlipidemic mice, indicating a distinct role in metabolic regulation.
Macrophage inflammatory protein-1α (CCL3) plays a well-known role in infectious and viral diseases; however, its contribution to atherosclerotic lesion formation and lipid metabolism has not been determined. Low density lipoprotein receptor deficient (LDLR(-/-)) mice were transplanted with bone marrow from CCL3(-/-) or C57BL/6 wild type donors. After 6 and 12 weeks on western diet (WD), recipients of CCL3(-/-) marrow demonstrated lower plasma cholesterol and triglyceride concentrations compared to recipients of C57BL/6 marrow. Atherosclerotic lesion area was significantly lower in female CCL3(-/-) recipients after 6 weeks and in male CCL3(-/-) recipients after 12 weeks of WD feeding (P<0.05). Surprisingly, male CCL3(-/-) recipients had a 50% decrease in adipose tissue mass after WD-feeding, and plasma insulin, and leptin levels were also significantly lower. These results were specific to CCL3, as LDLR(-/-) recipients of monocyte chemoattractant protein(-/-) (CCL2) marrow were not protected from the metabolic consequences of high fat feeding. Despite these improvements in LDLR(-/-) recipients of CCL3(-/-) marrow in the bone marrow transplantation (BMT) model, double knockout mice, globally deficient in both proteins, did not have decreased body weight, plasma lipids, or atherosclerosis compared with LDLR(-/-) controls. Finally, there were no differences in myeloid progenitors or leukocyte populations, indicating that changes in body weight and plasma lipids in CCL3(-/-) recipients was not due to differences in hematopoiesis. Taken together, these data implicate a role for CCL3 in lipid metabolism in hyperlipidemic mice following hematopoietic reconstitution.
No takes yet. Share an insight, caveat, or question.
Kennedy et al. (2012) studied Atherosclerosis and hyperlipidemia (murine LDLR-/- model). CCL3(-/-) bone marrow transplantation vs. C57BL/6 wild-type or CCL2(-/-) bone marrow transplantation was evaluated on Atherosclerotic lesion area, plasma lipid concentrations, and adipose tissue mass (50% decrease in adipose tissue mass in male recipients, p=<0.05). CCL3(-/-) bone marrow transplantation in LDLR(-/-) mice reduced atherosclerotic lesion area and decreased adipose tissue mass by 50% in males compared with wild-type marrow.
Synapse has enriched 10 related papers. Consider them for comparative context: